Dr Cath Mummery (UCL Queen Square Institute of Neurology) comments on the clinical trials led by UCL for miridesap, a drug developed by Professor Sir Mark Pepys (UCL Medicine) which may slow down the progression of Alzheimer's disease.
Read: Times (£), More: Express
Close
